Prolonged Mean VO2 Response Time in Systolic Heart Failure: an Indicator of Impaired Right Ventricular-pulmonary Vascular Function
Overview
Authors
Affiliations
Background: In patients with left ventricular systolic dysfunction (LVSD), the rate at which oxygen uptake (VO2) increases on initiation of exercise is inadequate to match metabolic demands. To gain mechanistic insights into delayed VO2 kinetics in LVSD, we simultaneously assessed hemodynamic measurements, ventilatory parameters, and peripheral oxygen usage during exercise.
Methods And Results: Forty-two patients with symptomatic LVSD (age, 59±2 years [mean±SEM]; LV ejection fraction, 30±1%) and 17 controls (LV ejection fraction, 68±1%) underwent maximum upright cycle ergometry cardiopulmonary exercise testing. Hemodynamic monitoring and first-pass radionuclide ventriculography were performed at rest and during exercise. VO2 kinetics were quantified by mean response time (MRT), which was significantly longer in patients with LVSD compared with controls (64±3 versus 45±5 s; P=0.004). In LVSD patients, MRT was associated with higher biventricular filling pressures and reduced cardiac output during early exercise. LVSD patients with MRT ≥60 s, compared with LVSD subjects with MRT <60 s, demonstrated greater impairment in right ventricular-pulmonary vascular function during exercise as evidenced by lower right ventricular ejection fraction (35±2 versus 45±2%; P=0.03), steeper increment in transpulmonary gradient relative to cardiac output (3.7 versus 2.2 mm Hg/L; P<0.001), and increased ventilatory dead-space fraction (17±1 versus 12±2%; P=0.03). In contrast, MRT was not associated with LV ejection fraction (rest, exercise), PaO2, hemoglobin, or resting pulmonary function test results.
Conclusions: Delayed oxygen uptake on initiation of exercise (ie, MRT ≥60 s) in LVSD is closely related to impaired right ventricular-pulmonary vascular function and may represent an important surrogate for inability to augment RV performance during physical activity in patients with heart failure.
Kabbadj K, Taiek N, El Hjouji W, El Karrouti O, El Hangouche A US Cardiol. 2025; 18():e22.
PMID: 39872828 PMC: 11770537. DOI: 10.15420/usc.2024.37.
Cipriano Jr G, da Luz Goulart C, Chiappa G, da Silva M, Silva N, do Vale Lira A Sci Rep. 2024; 14(1):22505.
PMID: 39341902 PMC: 11439022. DOI: 10.1038/s41598-024-72965-0.
Cardiopulmonary exercise test to detect cardiac dysfunction from pulmonary vascular disease.
Alotaibi M, Yang J, Papamatheakis D, McGuire W, Fernandes T, Morris T Respir Res. 2024; 25(1):121.
PMID: 38468264 PMC: 10926602. DOI: 10.1186/s12931-024-02746-w.
Gerhardy B, Orde S, Morgan L BMJ Open. 2023; 13(10):e074571.
PMID: 37848309 PMC: 10582947. DOI: 10.1136/bmjopen-2023-074571.
Walsh J, Stamenkovic A, Dawber J, Stapley P Front Sports Act Living. 2023; 4:1047369.
PMID: 36704263 PMC: 9871811. DOI: 10.3389/fspor.2022.1047369.